SNEDDS Formulation Research

Dioscin and diosgenin are lipophilic compounds. SNEDDS formulation research evaluates their dispersion, dissolution, permeability, and transport in lipid based delivery systems.

SNEDDS Formulation Measurements. Studies of self nanoemulsifying systems measure droplet formation, dissolution, intestinal transport, first pass exposure, and pharmacokinetic changes for lipophilic botanical compounds.

• Nano Emulsification. Upon GI contact, SNEDDS spontaneously forms lipid nano droplets under 200 nm. This dramatically increases the surface area for absorption.
• P gp Inhibition. SNEDDS surfactants inhibit P glycoprotein efflux transporters, preventing active efflux of compounds back into the gut lumen.
• Lymphatic Bypass. Nano droplets are packaged into chylomicrons absorbed via lymphatic lacteals, bypassing hepatic first pass metabolism.
• Systemic Saturation. Active compounds enter circulation at full potency, achieving significantly higher plasma concentrations than conventional oral delivery methods.

SNEDDS Permeation Models

Training and Muscle Research

Diosgenin is a steroidal sapogenin. Structural diagrams compare its steroidal scaffold with related molecules, including DHEA.

• Resistance Training Research. Studies show significant improvements in one repetition maximum leg press and bench press outcomes. The cited human study by Horii et al. measured muscle hypertrophy and strength outcomes during resistance training combined with Dioscorea esculenta intake, indicating enhanced training adaptation in athletes.
• Cell and Signaling Research. Research indicates Diosgenin protects C2C12 myoblasts from oxidative damage by attenuating mitochondrial ROS generation and regulating the mitochondrial apoptotic pathway. The cited C2C12 study by Kostov et al. measured anabolic pathway markers following exposure to diosgenin and ecdysterone.
• Standardized Extract. The certificate of analysis reports a diosgenin concentration greater than 40 percent. The SNEDDS section describes the formulation measurements used to characterize delivery and maximize cellular absorption.

Cognitive and Brain Delivery Research

Neurological Research. Studies of diosgenin report cognitive, biomarker, and neurological pathway measurements across human and experimental models.

• Brain Delivery Measurements. A 2025 study by Ahmad et al. evaluated a diosgenin loaded nanoemulsion in an animal model and reported pharmacokinetic measurements demonstrating significantly improved blood brain barrier penetration and brain bioavailability for neuroprotection during cerebral ischemia.
• Cognitive Trial Data. The cited placebo controlled human studies by Tohda et al. and Inada et al. measured cognitive performance outcomes and plasma biomarkers following Dioscorea or diosgenin rich yam extract interventions. Findings suggest Diosgenin enhances cognitive function in healthy adults and ameliorates plasma biomarkers in cases of mild cognitive impairment.

Metabolic Pathway Research

• Metabolic Signaling. The cited studies examined GLUT 4 signaling, glucose metabolism, insulin sensitivity, and related metabolic endpoints. Dioscorea esculenta is documented to induce an increase in muscle sex steroid hormones associated with enhanced insulin sensitivity.

Measurement and Serving Guide

Measurement Guide. The marked dropper measures the serving in milliliters. The labeled range shown on this page begins at 0.5 mL and extends to 2.0 mL.

How long will your bottle last?

Note: 10 drops is approximately 0.5 mL. Max recommended dose is 2mL/day.

Scientific References

• Tohda C, Yang X, Matsui M, Inada Y, Kadomoto E, Nakada S, Watari H, Shibahara N. Diosgenin-Rich Yam Extract Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study of Healthy Adults. Nutrients. 2017 Oct 24;9(10):1160. doi: 10.3390/nu9101160.
• Inada, Y., Tohda, C., Sasabayashi, D., & Suzuki, M. (2024). Diosgenin-rich Yam (rhizome of Dioscorea batatas) extract ameliorates cognitive functions and plasma biomarkers for mild cognitive impairment and mild Alzheimer's disease: A randomized controlled trial. Phytomedicine Plus, 4(3), 100613.
• Ahmad, Niyaz, et al. "Formulation of a novel diosgenin-loaded nanoemulsion and its evaluation for improved brain bioavailability in the management of cerebral ischemia." Journal of Drug Delivery Science and Technology, vol. 114, 2025, p. 107468.
• Kostov T, Diel P, Isenmann E. Examination of the anabolic activity and mechanisms of action of the combination of Diosgenin and Ecdysterone in C2C12 myotubes. Toxicol Lett. 2024 Nov;401:181-189. doi: 10.1016/j.toxlet.2024.10.005.
• Horii N, Hasegawa N, Fujie S, Iemitsu K, Uchida M, Hamaoka T, Iemitsu M. Effects of Dioscorea esculenta intake with resistance training on muscle hypertrophy and strength in sprint athletes. J Clin Biochem Nutr. 2020 Nov;67(3):338-343. doi: 10.3164/jcbn.19-124.
• Semwal P, Painuli S, Abu-Izneid T, Rauf A, Sharma A, Daştan SD, Kumar M, Alshehri MM, Taheri Y, Das R, Mitra S, Emran TB, Sharifi-Rad J, Calina D, Cho WC. Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives. Oxid Med Cell Longev. 2022 May 29;2022:1035441.
• ur-Rehman, R., et al. "Diosgenin: A Potential Therapeutic Phytocompound for the Management of Atherosclerosis and Other Physiological Disorders." Natural Product Communications, 2024.
• Wang Z, Zhao S, Tao S, Hou G, Zhao F, Tan S, Meng Q. Dioscorea spp.: Bioactive Compounds and Potential for the Treatment of Inflammatory and Metabolic Diseases. Molecules. 2023 Mar 22;28(6):2878.
• Mohseni-Moghaddam P, Khanmohammadi M, Roghani M. Literature review on hepatoprotective effects of diosgenin: possible mechanisms of action. Front Pharmacol. 2023 Sep 12;14:1226548.
• Biswas, Soumili, et al. "Exploring the therapeutic potential of dioscin and diosgenin in neurological disorders." Brain Behavior and Immunity Integrative, vol. 7, 2024, p. 100069.
• Sato et al. Dioscorea esculenta-induced increase in muscle sex steroid hormones is associated with enhanced insulin sensitivity in a type 2 diabetes rat model. FASEB Journal. (2017).
• Poole et al. Chronic application and significant increase in 1RM leg press and 1RM bench press during strength training. (2010).
• Ikeuchi et al. (2006); Goh et al. (2020); Herrick et al. (2020). Improvements in endurance capacity in animal models and human interventions.